Acta Med. 2006, 49: 245-246

https://doi.org/10.14712/18059694.2017.141

Nitric Oxide and Systemic Sclerosis

Ľubica Cibičkováa, Tomáš Soukupa, Norbert Cibičekb, Jaroslav Chládekc

aCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, 2nd Department of Medicine, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Institute for Clinical Biochemistry and Diagnostics, Hradec Králové, Czech Republic
cCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Department of Pharmacology, Hradec Králové, Czech Republic

Received October 1, 2006
Accepted October 1, 2006

References

1. Allanore Y, Borderie D, Hilliquin P et al. Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells. Rheumatology 2001; 40:1089–96. <https://doi.org/10.1093/rheumatology/40.10.1089>
2. Cerinic MM, Kahaleh MB. Beauty and the Beast. The nitric oxide paradox in systemic sclerosis. Rheumatology 2002; 41:843–7. <https://doi.org/10.1093/rheumatology/41.8.843>
3. Cotton AS, Herrick AL, Jayson MIV, Freemont AJ. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin. J Pathol 189: 273–279 (1999). <https://doi.org/10.1002/(SICI)1096-9896(199910)189:2<273::AID-PATH413>3.0.CO;2-4>
4. Failli P, Palmieri L, D’Alfonso C et al. Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis. Nitric oxide 2002; 7:277–82. <https://doi.org/10.1016/S1089-8603(02)00120-9>
5. Fajac I, Kahan A, Menkes CJ, Dessanges JF, Dall’Ava-Santucci J, Dinh-Xuan AT. Increased nitric oxide in exhaled air in patients with systemic sclerosis. Clin Exp Rheumatol. 1998; 16(5):547–52.
6. Kharitonov SA, Cailes JB, Black CM, du Bois RM, Barnes PJ. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax. 1997; 52(12):1051–5. <https://doi.org/10.1136/thx.52.12.1051> <PubMed>
7. Kolb H, Kolb-Bachofen V. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunology Today 1998; 19(12):556–61. <https://doi.org/10.1016/S0167-5699(98)01366-8>
8. Rolla G, Colagrande P, Scappaticci E et al. Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension. J Rheumatol. 2000 Jul; 27(7):1693–8.
9. Romero LI, Zhang DN, Cooke JP et al. Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma. Vasc Med. 2000; 5(3):147–58. <https://doi.org/10.1177/1358836X0000500304>
10. Sud A, Khullar M, Wanchu A, Bannery P. Increased nitric oxide production in patiens with systemic sclerosis. Nitric oxide: Biology and Chemistry 2000; 4(6): 615–9. <https://doi.org/10.1006/niox.2000.0309>
11. Takagi K, Kawaguchi Y, Hara M, Sugiura T, Harigai M, Kamatani N. Serum nitric oxide (NO) levels in systemis sclerosis patients: correlation between NO levels and clinical features. Clin Exp Immunol 2003; 134:538–544. <https://doi.org/10.1111/j.1365-2249.2003.02320.x> <PubMed>
12. Yamamoto T, Sawada Y, Katayama I, Nishioka K. Increased production of nitric oxide stimulated by interlaukin-1β in peripheral blood mononuclear cells in patients with systemic sclerosis. British Journal of Rheumatology 1998; 37:1123–5. <https://doi.org/10.1093/rheumatology/37.10.1123>
13. Yamamoto T, Katayama I, Nishioka K. Nitric oxide production and inducible nitric oxide synthase experssion in systemic sclerosis. J Rheumatol. 1998 Feb; 25(2):314–7.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive